2021 bmw R1250 rt Review | First Ride: A few months back those kind folk at bmw uk loaned me the latest rt for a try - Here's my first ride on the bike.

Elon Musk’s obsession with the letter ‘X’ is well-documented, but BMW’s obsession is far more practical. When I reviewed the outgoing X3 last year, I felt it was clearly the driver’s choice in the ...

It's been a few years since I last rode a bmw RT, I don't know why it's been so long as it's a bike I instantly loved and has been in my mind as a possible replacement for my gs when the time comes.

CHICAGO, Jan 8 (Reuters) - An independent vaccine advisory group said on Thursday it will conduct a scientific evidence review of a vaccine used to prevent cervical and other cancers that U.S. health ...

I drove the 2025 BMW M5—here’s my honest take on its performance, comfort, and whether it still defines the super sedan. The 2025 BMW M5 blends twin-turbo V8 power with a plug-in hybrid system to ...

The iX3's new platform features a completely redesigned battery pack, offering higher energy density and lower costs compared to earlier models. It also includes a pair of more efficient electric ...

SOTOGRANDE, SPAIN—“All-new” is one of the most overused terms in the automotive industry, right up there with “dynamic” and “no-compromise.” It’s rarely accurate, either. All that begs the question: ...

The Rock of Gibraltar looms behind me as I stitch turns together behind the wheel of the 2027 BMW iX3. Over the course of the day, I’ll connect the dots between villages in Andalusia, with the instant ...

Arguably the world’s most iconic sport sedan, the BMW M3 backs up its reputation by delivering ferocious performance in a four-door package. Beyond combining sporty driving manners with everyday ...

The 2027 BMW iX3 isn’t just an electric version of the X3 small SUV—it’s a new start for BMW. It rides on a new platform built especially for electric vehicles, and it features a fresh design language ...

FDA leaders under President Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency's decisions from public ...